Top compounds associated with response to NUDT17


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.007
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.094 0.007
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.099 0.008
mRNA birinapant CTRPv2 pan-cancer AAC -0.1 0.008
mRNA Tamoxifen GDSC1000 pan-cancer AAC 0.091 0.009
mRNA VX-11e GDSC1000 pan-cancer AAC -0.089 0.009
mRNA IPA-3 GDSC1000 pan-cancer AAC 0.087 0.009
mRNA BI-2536 GDSC1000 pan-cancer AAC -0.14 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.01
mRNA thalidomide CTRPv2 pan-cancer AAC 0.14 0.01
Download CSV